Navigation Links
Insecticide combo delivers knockout punch
Date:3/11/2008

A cocktail of insecticides containing a plant protein and a common insecticide may be more lethal to crop pests than either ingredient used alone, according to biologists. The one-two punch also inhibits the insects' growth rate and reduces their chance of developing resistance.

"We found a synergistic effect, where the two insecticides together decreased the growth rate of caterpillars more than either one did alone," said Dawn Luthe, professor of plant stress biology at Penn State. "The insect mortality rate was also much greater than the sum of mortality rates when only one insecticide was used."

One of those insecticides, Bt, is commonly used around the world. When insects feed on plants genetically modified to produce Bt, the toxin binds to chemical receptors lining the insects' midgut. This disrupts the receptors function, eventually killing the insects. But researchers say some insects always survive the ordeal and over time subsequent populations could develop resistance to the toxin.

Luthe and her colleagues Srinidhi Mohan and Peter W. K. Ma, post-doctoral student and professor at Mississippi State University, and W. Paul Williams, research geneticist at the U.S Department of Agriculture studied a unique plant-based insecticide known as Mir1-CP.

Their goal is to see if Mir1-CP, when used in tandem with other biological pesticides, such as the Bt toxin, can prevent pests from developing resistance and make the toxin more effective.

"This protein, which we developed from certain strains of corn from Antigua, breaks down other proteins and peptides in the insects' gut," said Luthe, whose findings appear in the current issue of PLoS ONE.

Unlike Bt, Mir1-CP breaks down proteins in a protective membrane covering the midgut. This membrane acts as a barrier that protects the caterpillar from toxins in the diet, and cycles nutrients to the midgut.

"It is the caterpillar's first line of defense agai
'/>"/>

Contact: Amitabh Avasthi
axa47@psu.edu
814-865-9481
Penn State
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Natural insecticide re-created in the lab
2. Cigarette smoke, alcohol damage hearts worse as combo
3. e-Smart(R) Technologies Delivers Its New Super Smart Card(TM) in South Korea.
4. DOE JGI Community Sequencing Program delivers first moss genome
5. Lupus Research Institute strategy delivers $30 million in national funding
6. Mountain pine beetle: Canadas new government delivers
7. Scientists decipher mechanism behind antimicrobial hole punchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... MOUNTAIN VIEW, Calif. , July 30, 2015 ... products and services for gene function analysis and ... CRISPR Guide RNA (sgRNA) Knockout Library targeting all ... to specifically and permanently "knock out" a gene,s ... library provides a high throughput screening tool so ...
(Date:7/21/2015)... Today, ZTE announced its Android smartphone Axon, featuring FPC,s ... in 2015 that relate to sales of FPC1025 for this smartphone ... MSEK for 2015. Jörgen Lantto, CEO of FPC, comments: ... China and we are proud that ... Axon , its first smartphone ...
(Date:7/13/2015)... , Jul. 13, 2015 NXT-ID, Inc. ... a biometric authentication company focused on the growing ... filed provisional patent 62/188684 for BEHAVIORAL-DIRECTED ... another new convenient and secure method to make ... innovative payment methods, introduced with its groundbreaking voice-direct ...
Breaking Biology News(10 mins):CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4
... Hurricanes are the costliest natural disasters that strike ... withstand -- or fail to withstand a hurricane ... to protect human lives and enhance resiliency. ... the U.S. Department of Commerce today announced that the ...
... a millimeter in size. Exhibiting novel and often surprising properties, ... equally innovative products. In medical therapies, for example, tiny nanovehicles ... So far, the only way of testing these approaches has ... the activation of a transported gene inside a cell for ...
... is not the best way to monitor fish populations, if ... The fish population in coral reef areas is often assessed ... these methods may misrepresent the number of fish. A ... the divers and snorkelers who try to count them. Not ...
Cached Biology News:University of Miami receives stimulus funds for study of hurricane impacts on structures, ecosystems 2University of Miami receives stimulus funds for study of hurricane impacts on structures, ecosystems 3Chasing tiny vehicles 2Chasing tiny vehicles 3
(Date:7/30/2015)... --  Senomyx , Inc. (NASDAQ: SNMX ), a ... develop, and commercialize novel flavor ingredients for the food, ... for the second quarter 2015. "Moving ... track to achieve our commercial and financial goals," stated ... Company. "Since our last quarterly earnings report, our two ...
(Date:7/30/2015)... 2015 Ascendis Pharma A/S (Nasdaq: ... innovative TransCon technology to address significant unmet medical ... six-month Phase 2 study to evaluate the safety ... 53 treatment-naïve, pre-pubertal children with growth hormone deficiency, ... with the top-line results from our Phase 2 ...
(Date:7/30/2015)...  Discovery Laboratories, Inc. (Nasdaq: DSCO ) ... $1.0M tranche under a previously awarded Phase II ... up to $3.0 million to support continued development ... potential medical countermeasure to mitigate acute and chronic/late-phase ... initial $1.0 million under this grant in October ...
(Date:7/30/2015)... ... 30, 2015 , ... GEA's Pony™ NS2006L is ... up to 1500 bar. The sanitary design gauge of the NS2006L is well ... The Pony™ NS2006L homogenizer is an ideal solution for the processing of ...
Breaking Biology Technology:SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2
... April 4, 2012 Lixte Biotechnology Holdings, Inc. announced ... States Patent and Trademark Office for its lead histone ... Dr. John Kovach, founder and president of Lixte, ... of skin lymphomas and many other HDACi in various ...
... brain tumors with a combination of chemotherapy and radiation ... than two years after diagnosis. The effectiveness of the ... healthy brain tissue, which restricts chemotherapy access to the ... To address this challenge, researchers from the Georgia ...
... professor in the Department of Mechanical, Aerospace, and Nuclear ... Faculty Early Career Development Award (CAREER) from the National ... $500,000 award to further his research into the design ... CAREER Award is given to faculty members at the ...
Cached Biology Technology:Lixte Biotechnology Receives US Patent for Its Proprietary Histone Deacetylase Inhibitor 2Lixte Biotechnology Receives US Patent for Its Proprietary Histone Deacetylase Inhibitor 3Novel compound halts tumor spread, improves brain cancer treatment in animal studies 2Novel compound halts tumor spread, improves brain cancer treatment in animal studies 3Novel compound halts tumor spread, improves brain cancer treatment in animal studies 4Rensselaer professor Jie Lian receives NSF CAREER Award 2
Mouse monoclonal [1241] to Parainfluenza Virus type 2...
... 8G8/5 GenBank Accession Number : NM_002542 ... fusion protein corresponding to residues 166-223 of ... AP-2γ Formulation: 0.1M Tris-glycine, pH 7.4, 0.15M ... of glycerol to 30% Quality Assurance: routinely ...
Rabbit Anti-Human Secretory Carrier Membrane Protein 2 (SCAMP2 Polyclonal AntibodyOther Sub-Family: not assigned-Other Applications: Western Blot...
... Mucin 3 (MUC3) is a glycoprotein. ... a lesser extent in breast, lung and ... shows no cross-reaction with MUC1 and MUC2. ... human MUC3 Immunogen: MUC3 tandem ...
Biology Products: